Compounded GLP-1 safety

The safety concern behind the word "compounded"

The routine concern about a compounded GLP-1 product is whether it is the same thing as the one named on a brand label. The serious concern is what checks happen before it reaches you.

The U.S. Food and Drug Administration says the agency does not review compounded drugs for safety, effectiveness or quality before they are marketed. On semaglutide, the U.S. Food and Drug Administration says salt forms, including semaglutide sodium and semaglutide acetate, are different active ingredients than are used in the approved drugs.

Two questions, one after the other

• Semaglutide sodium or base, does the salt form matter? Start here, because it is about what is actually in the vial.
• Are compounded GLP-1 drugs reviewed before sale? The question with the most weight, and the one to carry into a clinic.

Obesity and drug references for comparison

For background, MedlinePlus maintains an obesity overview, Cleveland Clinic describes what obesity is, its classes, symptoms and causes, and MedlinePlus has drug information on tirzepatide injection for comparison with a product label.

The question worth asking before you pay

Ask the clinic to show you the product label and to say, in plain words, what the product is and who stands behind it. If it cannot, you have your answer before any money moves.